Learn more by exploring our library of videos, webinars, publications and more.


Content Type
Clinical Publications and Awards
April 15, 2024

100th Patient Enrolled in ROADS Phase 3 Clinical Trial

Our enrollment of the 100th patient in the ROADS GammaTile® Clinical Trial marks a pivotal moment. This trial focuses on newly diagnosed metastatic brain tumors.

Clinical Publications and Awards
February 23, 2024

CEO Per Langoe’s Vision for GammaTile®: Interview Highlights

GT Medical Technologies’ new CEO, Per Langoe, was interviewed by MedTech Dive about his plans to partner with healthcare providers and drive the adoption of GammaTile®, the only FDA-cleared revolutionary innovation in brain brachytherapy.

Clinical Publications and Awards
February 15, 2024

Insights from Jane Steen, VP of Marketing on Point-of-Care Marketing Evolution

Vice President of Marketing, Jane Steen, shared thought-provoking insights in an interview discussing the dynamic evolution of point-of-care marketing. Explore the key highlights here.

Clinical Publications and Awards
February 15, 2024

A new radiation therapy option for patients with brain tumors

Facing glioblastoma, Gilbert Stuart found hope with GammaTile introduced by Dartmouth Hitchcock Medical Center

November 06, 2023

Musella Foundation Webinar

October 11, 2023

More Uses for GammaTile

October 11, 2023

Case Study 2

Clinical Publications and Awards
January 27, 2022

Should Brachytherapy Play A Key Role in the Treatment of Adult Malignant Brain Tumors?

Opinion Piece:
Yes. Brachytherapy for the treatment of intracranial malignancies holds tremendous promise for optimal management of these frequently complex patients. – Drs. Weinberg and Beckham
No. The role of brachytherapy for malignant gliomas has been well investigated and found to confer no survival benefit for patients when combined with best surgical resection and standard external radiotherapy. – Dr. Barnett

Clinical Publications and Awards
January 10, 2022

CS-131 for Operable Intracranial Neoplasms

Dr. Kotecha: Radiation therapy can be delivered to the brain externally through machines, which is called external beam radiation therapy. This is the most common approach or use in radiation therapy and some terms that you may hear that are using this type of treatment are stereotactic radiosurgery. An alternative means of delivering radiation therapy is when radiation is actually implanted into the brain itself, and that is called brachytherapy.

Clinical Publications and Awards
December 27, 2021

GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas

Neuro-Oncology Advances 2021 | Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas [published online December 27, 2021]. https://doi.org/10.1093/noajnl/vdab185

Clinical Publications and Awards
November 09, 2021

A Call for Patients to Resume Routine Cancer Screenings and Treatment

During these uncertain times, remember to proactively reach out to patients and encourage them to resume routine cancer screenings to prevent delayed diagnoses that might lead to worsened health outcomes.

November 05, 2021

SVB Purpose Spotlight: GT Medical Technologies

Matt Likens describes GammaTile Therapy, GT Medical Technologies’ mission, and how working with Silicon Valley Bank has helped GT Medical achieve their purpose of improving the lives of patients with brain tumors.

October 17, 2021

Local Medical Center Is the First to Provide New Brain Tumor Treatment

Orange Park Medical Center is the first hospital in North Florida to provide a new brain tumor treatment the size of a computer chip.

GammaTile® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. For full product and safety information, refer to the Instructions for Use.